Guest guest Posted December 22, 2010 Report Posted December 22, 2010 - There's also the point of ethics in sport. Cheating is what you're doing if you breach the rules - and people scream quite loudly when someone say, breaks a rule on the field, right? If anything, people need to be less comfy about AAS and other cheats and perhaps return their thinking to a more level way of viewing ALL cheating as cheating. The Phantom aka Schaefer, CMT/RMT, competing powerlifter Denver, Colorado USA Anabolic steroids- where are the bodies. Ralph Giarnella MD wrote: You apparently missed the point of the article. There are numerous case studies of young weight lifters and body builders who abused AAS and died and subsequently underwent autopsy. These are individuals who had no other risk factors for heart disease. When a person dies of heart disease because of a bad diet the death certificate does not state that they died because they had a poor diet. It just states they died of a heart attack. Death certificates do not state that an individual died because of obesity nor does it state that they died as the result of smoking. Death certificates list the conditions caused by these conditions such as heart diseasea, diabetes, emphysema or copd. As a matter of fact in my state (Connecticut) only recently has there been a box to check off is smoking might have been a contributing cause of this persons death. There is no box to check for alcohol abuse, obesity or eating at Mcs. a There is plenty of science available in the literature concerning the dangers of AAS, however the AAS apologists conveninetly ignore the science. Casler writes: I think it is extremely important to take an informed viewpoint that looks at all the implications. Anabolic Steroids and other endocrine drugs can be abused or they can be used. This means don't be an apologist nor an alarmist regarding the subject. We also need to disassociate their medical use with the abuse and cheating usage in sports. While you can draw associations with cases that may have been caused by abuse, we should not let that hamper the proper medical use of such medications to improve health and the quality of life. There is MUCH evidence that the proper medical use will NOT cause heart and coronary disease, but it will reduce or prevent it. The hysteria that surrounds hormonal abuse is likely warranted, but it need be tempered and disconnected from their positive medical implementation. Insulin is another hormone more commonly used in a medical sense and is arguably more anabolic than testosterone. It is also even more dangerous if abused or used improperly, so I think we need adapt the same viewpoint to all exogenous hormonal use. Broad brush hand waving creates a strange phenomenon whereby the " good " that can be done thwarts the amount of research that needs to be carried out to be truly helpful. HRT (hormone replacement therapy) is beginning to gain an interest and it would seem that if the " balancing act " of using the medications properly is more sophisticated that it will in fact REDUCE cancers, heart disease, sarco and osteopenia, diabetes, metabolic syndrome, and many other ailments that manifest (especially) males as they suffer a reduction in testosterone production. Enlarged hearts and other heart conditions assigned to steroid abuse may certainly be true, but years before steroid abuse was around these same conditions fell many former athletes. I'm just suggesting not to throw the baby out with the bath water. I think in the future, if we can get beyond this publicity generated hysteria, so that endocrine science will advance and health and the quality of life will be enhanced and improved with greater understanding and implementation. Just like we now know more about nutrition, and how manipulating our intakes can be positive, we will likely see that we can also learn how to control hormonal/endocrine levels to a better and healthier result. Regards, Casler TRI-VECTOR 3-D Training Systems Century City, CA -II-----II- Quote
Guest guest Posted December 22, 2010 Report Posted December 22, 2010 Kenny, I don't think that an HBO story of steroid use covering what a few people call the lack of evidence supporting the dangers of using or abusing steroids a viable counter to the sample of evidence Dr. Ralph is providing, which is the tip of the iceberg when it comes to research regarding the use and abuse of AAS. Casey Gallagher CSCS Snohomish, WA USA > > > Ralph, > > You apparently can come up with defenitive data. > > Drug abuse of any medication cause health issues or leads you down the road to a quick demise. > > Drinking too my water will kill you, hyponatramia. > > There is plenty of data form medical experts and the federal government that counter your statements. Here a quick look at some of it. http://www.youtube.com/watch?v=z0LEj8IPHGU & feature=related > > I will be more than happy to provide with a plethra of data that refutes what you've presented. > > With that said, I am a proponent of just tell the truth and let the chips fall... > > Kenny Croxdale > Rio Rancho, NM > > > > > > Re: Anabolic steroids- where are the bodies. > > A common refrain amongst apologists for anabolic steroids is : Where are the > bodies? The bodies are in the cemetary ony the death certificated does not > state they died from steroids. The most likely cause of death heart disease. > It might be cardiac arrhythmia or acute MI. > > There is an excellent article in the American Journal of Cardiology which > reviews A total of 49 studies describing 1,467 athletes were reviewed to > investigate the cardiovascular effects of the abuse of AAS. > It cites 99 articles covering this topic. If you are interested in this topic > go to your local hospital Library and check out : > > Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids, > Blood Pressure, Left Ventricular Dimensions, and > > Rhythm > The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) - > Copyright © 2010 The American College of Cardiology - > > Because of copyright and space I cannot put the article here but I have taken > the time to excerpt some of the information I thought might be pertinent along > with the articles or journals cited. > > You are not likely to find these studies in your typical muscle magazine or > website. Some of these studies date back to the mid 80s and 90s. The > information is not new just conveniently ignored. > > *********************** > > Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids, > Blood Pressure, Left Ventricular Dimensions, and Rhythm > > The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) - > Copyright © 2010 The American College of Cardiology - > > AAS and abnormal plasma lipoproteins > > AAS abuse has been linked with abnormal plasma lipoproteins (Table 1). Several > studies suggest that AAS abuse in athletes increase low-density lipoprotein > (LDL) > > levels by >20% [14] , [36] , [37] , [38] and decrease high-density lipoprotein > (HDL) levels by 20% to 70%. [13] , [14] , [37] , [39] , [40] , [41] , [42] , > [43] , [44] > > By some estimates, these lipoprotein abnormalities increase > the risk for coronary artery disease by three- to sixfold. [14] , [45] > > 13 Sader M.A., Griffiths K.A., McCredie R.J., Handelsman D.J., Celermajer > D.S.: Androgenic anabolic steroids and arterial structure and function in male > > bodybuilders. J Am Coll Cardiol 37. 224-230.2001; Abstract > > 14 Lenders J.W., Demacker P.N., Vos J.A., Jansen P.L., Hoitsma A.J., Van't Laar > A., Thien T.: Deleterious effects of anabolic steroids on serum lipoproteins, > blood > > pressure, and liver function in amateur bodybuilders. Int J Sports Med 9. > 19-23.1988; Abstrac > 36 Lajarin F., Zaragoza R., r I., ez- P.: Evolution of > serum lipids in two male bodybuilders using anabolic steroids. Clin Chem 42. > 970- > > 972.1996; Abstract > 37 McKillop G., Ballantyne D.: Lipoprotein analysis in bodybuilders. Int J > Cardiol 17. 281-288.1987; Abstract > > 38 Palatini P., Giada F., Garavelli G., Sinisi F., L., Michieletto M., > Baldo-Enzi G.: Cardiovascular effects of anabolic steroids in weight-trained > subjects. J Clin > > Pharmacol 36. 1132-1140.1996; Abstract > 39 Baldo-Enzi G., Giada F., Zuliani G., Baroni L., Vitale E., Enzi G., > Magnanini P., Fellin R.: Lipid and apoprotein modifications in body builders > during and after self- > > administration of anabolic steroids. Metabolism 39. 203-208.1990; Abstract > 40 Fröhlich J., Kullmer T., Urhausen A., Bergmann R., Kindermann W.: Lipid > profile of body builders with and without self-administration of anabolic > steroids. Eur J > > Appl Physiol 59. 98-103.1989; 41 Hartgens F., Rietjens G., K > 41 Hartgens F., Rietjens G., Keizer H.A., Kuipers H., Wolffenbuttel B.: > Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a). > Br J Sport > > Med 38. 253-259.2004; > > 42 Lane H., Grace F., J.C., K., Cockcroft J., Scanlon M.F., Davies > J.S.: Impaired vasoreactivity in bodybuilders using androgenic anabolic > steroids. Eur J > > Clin Invest 36. 483-488.2006; Abstract > 43 Urhausen A., Albers T., Kindermann W.: Are the cardiac effects of anabolic > steroid abuse in strength athletes reversible?. Heart 90. 496-501.2004; > Abstract > > 44 Zuliani U., Bernardini B., Catapano A., Campana M., Cerioli G., Spattini > M.: Effects of anabolic steroids, testosterone, and HGH on blood lipids and > > echocardiographic parameteres in body builders. Int J Sports Med 10. > 62-66.1989; Abstract > > 45 Glazer G.: Atherogenic effects of anabolic steroids on serum lipid levels. > A literature reviewArch Intern Med 151. 1925-1933.1991; Abstract > > AAS, acute MI, and sudden death > Alarming data have linked AAS with fatal events, although these are mostly > case-control studies and case reports of acute coronary syndromes, MIs, and > ventricular > > arrhythmias. [24] , [46] , [83] , [84] , [85] , [86] , [87] , [88] > > 88 Fineschi V., Riezzo I., Centini F., Silingardi E., Licata M., Beduschi G., > Karch S.B.: Sudden cardiac death during anabolic steroid abuse: morphologic and > > toxicologic findings in two fatal cases of bodybuilders. Int J Legal Med 121. > 48-53.2007; Abstract > > 89 Sullivan M.L., ez C.M., Gennis P., Gallagher E.J.: The cardiac > toxicity of anabolic steroids. Prog Cardiovasc Dis 41. 1-15.1998; Abstract > > 90 Ferenchick G.: Anabolic/androgenic steroid abuse and thrombosis: is there a > connection?. Med Hypotheses 35. 27-31.1991; Abstract > > 91 Roeggia M., Heinz G., Werba E., Roeggla G.: Cardiac tamponade in a > 21-year-old body builder with anabolica abuse. Br J Clin Pract 50. > 411-412.1996; Citation > > 92 Ferenchick G., Adelman S.: Myocardial infarction associated with anabolic > steroid use in a previously healthy 37-year-old weight lifter. Am Heart J 124. > 507- > > 508.1992; Citation > 93 Huie M.: An acute myocardial infarction occurring in an anabolic steroid > user. Med Sci Sport Exer 26. 408-413.1994; > > 94 Fisher M., Appleby M., Rittoo D., Cotter L.: Myocardial infarction with > extensive intracoronary thrombus induced by anabolic steroids. Br J Clin Pract > 50. 222- > > 223.1996; Abstract > > a postmortem study of male Caucasian AAS abusers (aged 20 to 45 years) suggested > > primary cardiac pathology in 1/3, [23] > > 23 Thiblin I., Lindquist O., Rajs J.: Cause and manner of death among users of > anabolic androgenic steroids. J Forensic Sci 45. 16-23.2000; Abstract > > recent case-control study [24] , [25] suggested cardiac causes in 2/3 of deaths, > > with others being attributed to suicide, hepatic coma, and malignancy. > > 24 Parssinen M., Kujala U., Vartiainen E., Sarna S., Seppala T.: Increased > premature mortality of competitive powerlifters suspected to have used anabolic > agents. Int J Sports Med 21. 225-227.2000; Abstrac > > 25 Parssinen M., Seppala T.: Steroid use and long-term health risks in former > athletes. Sports Med 2002. 83-84.2002; 2 > > Hausmann et al [84] describe a 23-year-old male bodybuilder who abused AAS and > experienced sudden cardiac arrest. Postmortem examination revealed ventricular > hypertrophy, myocardial fibrosis, and acute MI, and the cause of death was > attributed to arrhythmic sudden death secondary to AAS abuse. > 84 Hausmann R., Hammer S., Betz P.: Performance enhancing drugs (doping agents) > and sudden death†" a case report and review of the literature. Int J Legal Med > 111. 261-264.1998; Abstrac > > McNutt et al[46] reported an acute MI in a 22-year-old bodybuilder who admitted > to AAS abuse but lacked cardiac risk factors. The patient presented with > markedly elevated LDL (596 mg/dl) and depressed HDL (14 mg/dl) yet had no family > > history of premature atherosclerosis or cardiac events. Within a month of > discontinuing AAS, his LDL decreased to 220 mg/dl and his HDL increased to 35 > mg/dl. > > 46 McNutt R.A., Ferenchick G.S., Kirlin P.C., Hamlin N.J.: Acute myocardial > infarction in a 22-year-old world class weight lifter using anabolic steroids. > Am J Cardiol62.164.1988; Citation > > 49 Bowman S.: Anabolic steroids and infarction. BMJ 300. 750.1990; Citation > > Figure 1 shows the presenting electrocardiogram of a 25-year-old male athlete > who abused nandrolone and presented with an acute MI without traditional cardiac > > risk factors. Acute angiography revealed extensive left anterior descending > coronary artery thrombosis, which was managed by thrombolysis. Angiography in > the subacute phase confirmed very mild luminal irregularity at the site of > previous thrombosis. > > 69 Kennedy C.: Myocardial infarction in association with misuse of anabolic > steroids. Ulster Med J 62. 174-176.1993; Citation > > The most commonly observed arrhythmias, typically occurring during physical > exertion, include atrial fibrillation, ventricular fibrillation, ventricular > tachycardia, and supraventricular and ventricular ectopic beats. [95] > 95 Furlanello F., Serdoz L.V., Cappato R., De Ambroggi L.: Illicit drugs and > cardiac arrhythmias in athletes. Eur J Cardiovasc Prev Rehabil 14. 487-494.2007; > > Abstract > > Dickerman et al [96] reported a 20-year-old male bodybuilder who > self-administered AAS 700 mg/week and had sudden cardiac arrest. Autopsy > indicated LVH with a cardiac mass >2 times the upper limit of normal. > > 96 Dickerman R.D., Schaller F., Prather I., McConathy W.J.: Sudden cardiac death > > in a 20-year-old bodybuilder using anabolic steroids. Cardiology 86. > 172-173.1995; Abstract > > ****************** > Ralph Giarnella MD > Southington Ct. USA > > Quote
Guest guest Posted December 22, 2010 Report Posted December 22, 2010 The Phantom wrote - There's also the point of ethics in sport. Cheating is what you're doing if you breach the rules - and people scream quite loudly when someone say, breaks a rule on the field, right? If anything, people need to be less comfy about AAS and other cheats and perhaps return their thinking to a more level way of viewing ALL cheating as cheating. Casler writes: Hi , I agree and haven't suggested supporting cheating in athletic competition in any way, nor have I suggested that the " abuse " of steroids is positive in any way. My point is to be careful in the message sent regarding all uses of exogenous hormones, so that they do not get a broad brush demonization. The facts of the matter are that one of the key elements to aging, and the diseases of aging is the reduced and changing hormonal production and profile. This is an area that needs some serious research, especially in this age of Baby Boomers increasing in numbers. We have a healthcare problem of incredible proportion and hormonal profiling appears to offer some serious benefits. You would be hard pressed to find any major disease that is not related to hormone deficiency, or profile. And this too needs to be approached seriously and not too enthusiastically as a " fountain of youth " without the proper research. I find it a great challenge to age with various nutritional and training strategies to maintain health and performance. I think in the future we will have a better grasp on various methods of maintaining a more youthful and healthy endocrine profile. The results will hopefully be a reduction in age related diseases. It is important that the general public is not led into an association of any employment of these means as cheating or dangerous when undertaken in a valid medical usage. My point is to make sure and define USE versus ABUSE. As well, there is also some discussion linking Steroid " abuse " /use to suicide. I find that a difficult case to make on its own. I think you could create a similar case to just being a teenager since they tend to commit suicide at an ALARMING rate. The real truth is likely somewhere in between. The answer is likely that the " emotional type " of person who feels the need to abuse drugs and or steroids is more likely to commit suicide. Most of them probably also drink coffee, and have other common practices, and environmental similarities but the correlation is not drawn. Rant over. . . . Regards, Casler TRI-VECTOR 3-D Training Systems Century City, CA -II-----II- Quote
Guest guest Posted December 22, 2010 Report Posted December 22, 2010 Tom, I am a bit puzzled as to what " gathering longevity data on athletes who threw the discus, shot, and hammer between 1960 and 1985 " has to do with this topic. Kenny Croxdale Rio Rancho, NM Re: Anabolic steroids- where are the bodies. A common refrain amongst apologists for anabolic steroids is : Where are the bodies? The bodies are in the cemetary ony the death certificated does not state they died from steroids. The most likely cause of death heart disease. It might be cardiac arrhythmia or acute MI. There is an excellent article in the American Journal of Cardiology which reviews A total of 49 studies describing 1,467 athletes were reviewed to investigate the cardiovascular effects of the abuse of AAS. It cites 99 articles covering this topic. If you are interested in this topic go to your local hospital Library and check out : Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids, Blood Pressure, Left Ventricular Dimensions, and Rhythm The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) - Copyright © 2010 The American College of Cardiology - Because of copyright and space I cannot put the article here but I have taken the time to excerpt some of the information I thought might be pertinent along with the articles or journals cited. You are not likely to find these studies in your typical muscle magazine or website. Some of these studies date back to the mid 80s and 90s. The information is not new just conveniently ignored. *********************** Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids, Blood Pressure, Left Ventricular Dimensions, and Rhythm The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) - Copyright © 2010 The American College of Cardiology - AAS and abnormal plasma lipoproteins AAS abuse has been linked with abnormal plasma lipoproteins (Table 1). Several studies suggest that AAS abuse in athletes increase low-density lipoprotein (LDL) levels by >20% [14] , [36] , [37] , [38] and decrease high-density lipoprotein (HDL) levels by 20% to 70%. [13] , [14] , [37] , [39] , [40] , [41] , [42] , [43] , [44] By some estimates, these lipoprotein abnormalities increase the risk for coronary artery disease by three- to sixfold. [14] , [45] 13 Sader M.A., Griffiths K.A., McCredie R.J., Handelsman D.J., Celermajer D.S.: Androgenic anabolic steroids and arterial structure and function in male bodybuilders. J Am Coll Cardiol 37. 224-230.2001; Abstract 14 Lenders J.W., Demacker P.N., Vos J.A., Jansen P.L., Hoitsma A.J., Van't Laar A., Thien T.: Deleterious effects of anabolic steroids on serum lipoproteins, blood pressure, and liver function in amateur bodybuilders. Int J Sports Med 9. 19-23.1988; Abstrac 36 Lajarin F., Zaragoza R., r I., ez- P.: Evolution of serum lipids in two male bodybuilders using anabolic steroids. Clin Chem 42. 970- 972.1996; Abstract 37 McKillop G., Ballantyne D.: Lipoprotein analysis in bodybuilders. Int J Cardiol 17. 281-288.1987; Abstract 38 Palatini P., Giada F., Garavelli G., Sinisi F., L., Michieletto M., Baldo-Enzi G.: Cardiovascular effects of anabolic steroids in weight-trained subjects. J Clin Pharmacol 36. 1132-1140.1996; Abstract 39 Baldo-Enzi G., Giada F., Zuliani G., Baroni L., Vitale E., Enzi G., Magnanini P., Fellin R.: Lipid and apoprotein modifications in body builders during and after self- administration of anabolic steroids. Metabolism 39. 203-208.1990; Abstract 40 Fröhlich J., Kullmer T., Urhausen A., Bergmann R., Kindermann W.: Lipid profile of body builders with and without self-administration of anabolic steroids. Eur J Appl Physiol 59. 98-103.1989; 41 Hartgens F., Rietjens G., K 41 Hartgens F., Rietjens G., Keizer H.A., Kuipers H., Wolffenbuttel B.: Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a). Br J Sport Med 38. 253-259.2004; 42 Lane H., Grace F., J.C., K., Cockcroft J., Scanlon M.F., Davies J.S.: Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids. Eur J Clin Invest 36. 483-488.2006; Abstract 43 Urhausen A., Albers T., Kindermann W.: Are the cardiac effects of anabolic steroid abuse in strength athletes reversible?. Heart 90. 496-501.2004; Abstract 44 Zuliani U., Bernardini B., Catapano A., Campana M., Cerioli G., Spattini M.: Effects of anabolic steroids, testosterone, and HGH on blood lipids and echocardiographic parameteres in body builders. Int J Sports Med 10. 62-66.1989; Abstract 45 Glazer G.: Atherogenic effects of anabolic steroids on serum lipid levels. A literature reviewArch Intern Med 151. 1925-1933.1991; Abstract AAS, acute MI, and sudden death Alarming data have linked AAS with fatal events, although these are mostly case-control studies and case reports of acute coronary syndromes, MIs, and ventricular arrhythmias. [24] , [46] , [83] , [84] , [85] , [86] , [87] , [88] 88 Fineschi V., Riezzo I., Centini F., Silingardi E., Licata M., Beduschi G., Karch S.B.: Sudden cardiac death during anabolic steroid abuse: morphologic and toxicologic findings in two fatal cases of bodybuilders. Int J Legal Med 121. 48-53.2007; Abstract 89 Sullivan M.L., ez C.M., Gennis P., Gallagher E.J.: The cardiac toxicity of anabolic steroids. Prog Cardiovasc Dis 41. 1-15.1998; Abstract 90 Ferenchick G.: Anabolic/androgenic steroid abuse and thrombosis: is there a connection?. Med Hypotheses 35. 27-31.1991; Abstract 91 Roeggia M., Heinz G., Werba E., Roeggla G.: Cardiac tamponade in a 21-year-old body builder with anabolica abuse. Br J Clin Pract 50. 411-412.1996; Citation 92 Ferenchick G., Adelman S.: Myocardial infarction associated with anabolic steroid use in a previously healthy 37-year-old weight lifter. Am Heart J 124. 507- 508.1992; Citation 93 Huie M.: An acute myocardial infarction occurring in an anabolic steroid user. Med Sci Sport Exer 26. 408-413.1994; 94 Fisher M., Appleby M., Rittoo D., Cotter L.: Myocardial infarction with extensive intracoronary thrombus induced by anabolic steroids. Br J Clin Pract 50. 222- 223.1996; Abstract a postmortem study of male Caucasian AAS abusers (aged 20 to 45 years) suggested primary cardiac pathology in 1/3, [23] 23 Thiblin I., Lindquist O., Rajs J.: Cause and manner of death among users of anabolic androgenic steroids. J Forensic Sci 45. 16-23.2000; Abstract recent case-control study [24] , [25] suggested cardiac causes in 2/3 of deaths, with others being attributed to suicide, hepatic coma, and malignancy. 24 Parssinen M., Kujala U., Vartiainen E., Sarna S., Seppala T.: Increased premature mortality of competitive powerlifters suspected to have used anabolic agents. Int J Sports Med 21. 225-227.2000; Abstrac 25 Parssinen M., Seppala T.: Steroid use and long-term health risks in former athletes. Sports Med 2002. 83-84.2002; 2 Hausmann et al [84] describe a 23-year-old male bodybuilder who abused AAS and experienced sudden cardiac arrest. Postmortem examination revealed ventricular hypertrophy, myocardial fibrosis, and acute MI, and the cause of death was attributed to arrhythmic sudden death secondary to AAS abuse. 84 Hausmann R., Hammer S., Betz P.: Performance enhancing drugs (doping agents) and sudden death—a case report and review of the literature. Int J Legal Med 111. 261-264.1998; Abstrac McNutt et al[46] reported an acute MI in a 22-year-old bodybuilder who admitted to AAS abuse but lacked cardiac risk factors. The patient presented with markedly elevated LDL (596 mg/dl) and depressed HDL (14 mg/dl) yet had no family history of premature atherosclerosis or cardiac events. Within a month of discontinuing AAS, his LDL decreased to 220 mg/dl and his HDL increased to 35 mg/dl. 46 McNutt R.A., Ferenchick G.S., Kirlin P.C., Hamlin N.J.: Acute myocardial infarction in a 22-year-old world class weight lifter using anabolic steroids. Am J Cardiol62.164.1988; Citation 49 Bowman S.: Anabolic steroids and infarction. BMJ 300. 750.1990; Citation Figure 1 shows the presenting electrocardiogram of a 25-year-old male athlete who abused nandrolone and presented with an acute MI without traditional cardiac risk factors. Acute angiography revealed extensive left anterior descending coronary artery thrombosis, which was managed by thrombolysis. Angiography in the subacute phase confirmed very mild luminal irregularity at the site of previous thrombosis. 69 Kennedy C.: Myocardial infarction in association with misuse of anabolic steroids. Ulster Med J 62. 174-176.1993; Citation The most commonly observed arrhythmias, typically occurring during physical exertion, include atrial fibrillation, ventricular fibrillation, ventricular tachycardia, and supraventricular and ventricular ectopic beats. [95] 95 Furlanello F., Serdoz L.V., Cappato R., De Ambroggi L.: Illicit drugs and cardiac arrhythmias in athletes. Eur J Cardiovasc Prev Rehabil 14. 487-494.2007; Abstract Dickerman et al [96] reported a 20-year-old male bodybuilder who self-administered AAS 700 mg/week and had sudden cardiac arrest. Autopsy indicated LVH with a cardiac mass >2 times the upper limit of normal. 96 Dickerman R.D., Schaller F., Prather I., McConathy W.J.: Sudden cardiac death in a 20-year-old bodybuilder using anabolic steroids. Cardiology 86. 172-173.1995; Abstract ****************** Ralph Giarnella MD Southington Ct. USA Quote
Guest guest Posted December 23, 2010 Report Posted December 23, 2010 Kenny, I read your post and in it you stated, " There is plenty of data form [sic] medical experts and the federal government that counter your statements. (Here's) a quick look at some of it. " You then used a news show, which as Dr. Ralph posted, lacks credibility and validity in it's claims, to support your point. If you have a plethera of evidence to support your claim that there is " plenty of data " to refute Dr. Ralph's point, please, by all means share it. Casey Gallagher CSCS Snohomish, WA USA > > Casey, > > I stated that the Real Sports report with Armen Keteyian (currently with CBS News) was " a quick look at it " ...that meanint it provided some information on the subject. > > I have some additional in depth documentation on the matter. > > As I previously stated, abuse of AAS or for that matter any other medication will eventually cause problems. Please re-read my post. > > Kenny Croxdale, CSCS > Rio Rancho, NM > > > > > > Re: Anabolic steroids- where are the bodies. > > > > > Kenny, > > I don't think that an HBO story of steroid use covering what a few people call the lack of evidence supporting the dangers of using or abusing steroids a viable counter to the sample of evidence Dr. Ralph is providing, which is the tip of the iceberg when it comes to research regarding the use and abuse of AAS. > > ===================== > Quote
Guest guest Posted December 23, 2010 Report Posted December 23, 2010 Kenny, You're not serious? Steroid use among these athletes during that period was extremely high. While we can't broach this question directly, the data might provide some relevant information on the topic. Tom Fahey California State University, Chico Re: Anabolic steroids- where are the bodies. A common refrain amongst apologists for anabolic steroids is : Where are the bodies? The bodies are in the cemetary ony the death certificated does not state they died from steroids. The most likely cause of death heart disease. It might be cardiac arrhythmia or acute MI. There is an excellent article in the American Journal of Cardiology which reviews A total of 49 studies describing 1,467 athletes were reviewed to investigate the cardiovascular effects of the abuse of AAS. It cites 99 articles covering this topic. If you are interested in this topic go to your local hospital Library and check out : Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids, Blood Pressure, Left Ventricular Dimensions, and Rhythm The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) - Copyright © 2010 The American College of Cardiology - Because of copyright and space I cannot put the article here but I have taken the time to excerpt some of the information I thought might be pertinent along with the articles or journals cited. You are not likely to find these studies in your typical muscle magazine or website. Some of these studies date back to the mid 80s and 90s. The information is not new just conveniently ignored. *********************** Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids, Blood Pressure, Left Ventricular Dimensions, and Rhythm The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) - Copyright © 2010 The American College of Cardiology - AAS and abnormal plasma lipoproteins AAS abuse has been linked with abnormal plasma lipoproteins (Table 1). Several studies suggest that AAS abuse in athletes increase low-density lipoprotein (LDL) levels by >20% [14] , [36] , [37] , [38] and decrease high-density lipoprotein (HDL) levels by 20% to 70%. [13] , [14] , [37] , [39] , [40] , [41] , [42] , [43] , [44] By some estimates, these lipoprotein abnormalities increase the risk for coronary artery disease by three- to sixfold. [14] , [45] 13 Sader M.A., Griffiths K.A., McCredie R.J., Handelsman D.J., Celermajer D.S.: Androgenic anabolic steroids and arterial structure and function in male bodybuilders. J Am Coll Cardiol 37. 224-230.2001; Abstract 14 Lenders J.W., Demacker P.N., Vos J.A., Jansen P.L., Hoitsma A.J., Van't Laar A., Thien T.: Deleterious effects of anabolic steroids on serum lipoproteins, blood pressure, and liver function in amateur bodybuilders. Int J Sports Med 9. 19-23.1988; Abstrac 36 Lajarin F., Zaragoza R., r I., ez- P.: Evolution of serum lipids in two male bodybuilders using anabolic steroids. Clin Chem 42. 970- 972.1996; Abstract 37 McKillop G., Ballantyne D.: Lipoprotein analysis in bodybuilders. Int J Cardiol 17. 281-288.1987; Abstract 38 Palatini P., Giada F., Garavelli G., Sinisi F., L., Michieletto M., Baldo-Enzi G.: Cardiovascular effects of anabolic steroids in weight-trained subjects. J Clin Pharmacol 36. 1132-1140.1996; Abstract 39 Baldo-Enzi G., Giada F., Zuliani G., Baroni L., Vitale E., Enzi G., Magnanini P., Fellin R.: Lipid and apoprotein modifications in body builders during and after self- administration of anabolic steroids. Metabolism 39. 203-208.1990; Abstract 40 Fröhlich J., Kullmer T., Urhausen A., Bergmann R., Kindermann W.: Lipid profile of body builders with and without self-administration of anabolic steroids. Eur J Appl Physiol 59. 98-103.1989; 41 Hartgens F., Rietjens G., K 41 Hartgens F., Rietjens G., Keizer H.A., Kuipers H., Wolffenbuttel B.: Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a). Br J Sport Med 38. 253-259.2004; 42 Lane H., Grace F., J.C., K., Cockcroft J., Scanlon M.F., Davies J.S.: Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids. Eur J Clin Invest 36. 483-488.2006; Abstract 43 Urhausen A., Albers T., Kindermann W.: Are the cardiac effects of anabolic steroid abuse in strength athletes reversible?. Heart 90. 496-501.2004; Abstract 44 Zuliani U., Bernardini B., Catapano A., Campana M., Cerioli G., Spattini M.: Effects of anabolic steroids, testosterone, and HGH on blood lipids and echocardiographic parameteres in body builders. Int J Sports Med 10. 62-66.1989; Abstract 45 Glazer G.: Atherogenic effects of anabolic steroids on serum lipid levels. A literature reviewArch Intern Med 151. 1925-1933.1991; Abstract AAS, acute MI, and sudden death Alarming data have linked AAS with fatal events, although these are mostly case-control studies and case reports of acute coronary syndromes, MIs, and ventricular arrhythmias. [24] , [46] , [83] , [84] , [85] , [86] , [87] , [88] 88 Fineschi V., Riezzo I., Centini F., Silingardi E., Licata M., Beduschi G., Karch S.B.: Sudden cardiac death during anabolic steroid abuse: morphologic and toxicologic findings in two fatal cases of bodybuilders. Int J Legal Med 121. 48-53.2007; Abstract 89 Sullivan M.L., ez C.M., Gennis P., Gallagher E.J.: The cardiac toxicity of anabolic steroids. Prog Cardiovasc Dis 41. 1-15.1998; Abstract 90 Ferenchick G.: Anabolic/androgenic steroid abuse and thrombosis: is there a connection?. Med Hypotheses 35. 27-31.1991; Abstract 91 Roeggia M., Heinz G., Werba E., Roeggla G.: Cardiac tamponade in a 21-year-old body builder with anabolica abuse. Br J Clin Pract 50. 411-412.1996; Citation 92 Ferenchick G., Adelman S.: Myocardial infarction associated with anabolic steroid use in a previously healthy 37-year-old weight lifter. Am Heart J 124. 507- 508.1992; Citation 93 Huie M.: An acute myocardial infarction occurring in an anabolic steroid user. Med Sci Sport Exer 26. 408-413.1994; 94 Fisher M., Appleby M., Rittoo D., Cotter L.: Myocardial infarction with extensive intracoronary thrombus induced by anabolic steroids. Br J Clin Pract 50. 222- 223.1996; Abstract a postmortem study of male Caucasian AAS abusers (aged 20 to 45 years) suggested primary cardiac pathology in 1/3, [23] 23 Thiblin I., Lindquist O., Rajs J.: Cause and manner of death among users of anabolic androgenic steroids. J Forensic Sci 45. 16-23.2000; Abstract recent case-control study [24] , [25] suggested cardiac causes in 2/3 of deaths, with others being attributed to suicide, hepatic coma, and malignancy. 24 Parssinen M., Kujala U., Vartiainen E., Sarna S., Seppala T.: Increased premature mortality of competitive powerlifters suspected to have used anabolic agents. Int J Sports Med 21. 225-227.2000; Abstrac 25 Parssinen M., Seppala T.: Steroid use and long-term health risks in former athletes. Sports Med 2002. 83-84.2002; 2 Hausmann et al [84] describe a 23-year-old male bodybuilder who abused AAS and experienced sudden cardiac arrest. Postmortem examination revealed ventricular hypertrophy, myocardial fibrosis, and acute MI, and the cause of death was attributed to arrhythmic sudden death secondary to AAS abuse. 84 Hausmann R., Hammer S., Betz P.: Performance enhancing drugs (doping agents) and sudden death—a case report and review of the literature. Int J Legal Med 111. 261-264.1998; Abstrac McNutt et al[46] reported an acute MI in a 22-year-old bodybuilder who admitted to AAS abuse but lacked cardiac risk factors. The patient presented with markedly elevated LDL (596 mg/dl) and depressed HDL (14 mg/dl) yet had no family history of premature atherosclerosis or cardiac events. Within a month of discontinuing AAS, his LDL decreased to 220 mg/dl and his HDL increased to 35 mg/dl. 46 McNutt R.A., Ferenchick G.S., Kirlin P.C., Hamlin N.J.: Acute myocardial infarction in a 22-year-old world class weight lifter using anabolic steroids. Am J Cardiol62.164.1988; Citation 49 Bowman S.: Anabolic steroids and infarction. BMJ 300. 750.1990; Citation Figure 1 shows the presenting electrocardiogram of a 25-year-old male athlete who abused nandrolone and presented with an acute MI without traditional cardiac risk factors. Acute angiography revealed extensive left anterior descending coronary artery thrombosis, which was managed by thrombolysis. Angiography in the subacute phase confirmed very mild luminal irregularity at the site of previous thrombosis. 69 Kennedy C.: Myocardial infarction in association with misuse of anabolic steroids. Ulster Med J 62. 174-176.1993; Citation The most commonly observed arrhythmias, typically occurring during physical exertion, include atrial fibrillation, ventricular fibrillation, ventricular tachycardia, and supraventricular and ventricular ectopic beats. [95] 95 Furlanello F., Serdoz L.V., Cappato R., De Ambroggi L.: Illicit drugs and cardiac arrhythmias in athletes. Eur J Cardiovasc Prev Rehabil 14. 487-494.2007; Abstract Dickerman et al [96] reported a 20-year-old male bodybuilder who self-administered AAS 700 mg/week and had sudden cardiac arrest. Autopsy indicated LVH with a cardiac mass >2 times the upper limit of normal. 96 Dickerman R.D., Schaller F., Prather I., McConathy W.J.: Sudden cardiac death in a 20-year-old bodybuilder using anabolic steroids. Cardiology 86. 172-173.1995; Abstract ****************** Ralph Giarnella MD Southington Ct. USA Quote
Guest guest Posted December 23, 2010 Report Posted December 23, 2010 All, Having experienced the AAS world directly as it existed in powerlifting, and tangentially as it was in the track and field throwing events, from the late 60’s up until the mid-80’s, I would like to ask this discussion to not overlook the point made by Dr. Giarnella: supra-physiological. In my experience, those who used AAS initially, likely a strong majority, generally kept to doses within or at least close to FDA guidelines, interspersed with phases of abstinence. Over time, I noticed this practice was gradually being displaced by reckless dose-escalation, stacking of agents, both oral and injectable, and a reluctance to “get clean”, even for a brief period of time. So while the incidence of drug use during that period (1960-1985) was indeed likely very high as noted, it was not initially typified by the prevalent insanity that came later, circa late 70’s and onward: the latter being one of the major reason I elected to stop use personally, along with the unknowns regarding use over many years. Just my $0.02... Regards and Happy holidays! Dr. Jim Klostergaard Houston, TX On 12/23/10 10:56 AM, " Tom Fahey " <discusdoc@...> wrote: Kenny, You're not serious? Steroid use among these athletes during that period was extremely high. While we can't broach this question directly, the data might provide some relevant information on the topic. Tom Fahey California State University, Chico Re: Anabolic steroids- where are the bodies. A common refrain amongst apologists for anabolic steroids is : Where are the bodies? The bodies are in the cemetary ony the death certificated does not state they died from steroids. The most likely cause of death heart disease. It might be cardiac arrhythmia or acute MI. There is an excellent article in the American Journal of Cardiology which reviews A total of 49 studies describing 1,467 athletes were reviewed to investigate the cardiovascular effects of the abuse of AAS. It cites 99 articles covering this topic. If you are interested in this topic go to your local hospital Library and check out : Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids, Blood Pressure, Left Ventricular Dimensions, and Rhythm The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) - The American College of Cardiology - Because of copyright and space I cannot put the article here but I have taken the time to excerpt some of the information I thought might be pertinent along with the articles or journals cited. You are not likely to find these studies in your typical muscle magazine or website. Some of these studies date back to the mid 80s and 90s. The information is not new just conveniently ignored. *********************** Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids, Blood Pressure, Left Ventricular Dimensions, and Rhythm The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) - The American College of Cardiology - AAS and abnormal plasma lipoproteins AAS abuse has been linked with abnormal plasma lipoproteins (Table 1). Several studies suggest that AAS abuse in athletes increase low-density lipoprotein (LDL) levels by >20% [14] , [36] , [37] , [38] and decrease high-density lipoprotein (HDL) levels by 20% to 70%. [13] , [14] , [37] , [39] , [40] , [41] , [42] , [43] , [44] By some estimates, these lipoprotein abnormalities increase the risk for coronary artery disease by three- to sixfold. [14] , [45] 13 Sader M.A., Griffiths K.A., McCredie R.J., Handelsman D.J., Celermajer D.S.: Androgenic anabolic steroids and arterial structure and function in male bodybuilders. J Am Coll Cardiol 37. 224-230.2001; Abstract 14 Lenders J.W., Demacker P.N., Vos J.A., Jansen P.L., Hoitsma A.J., Van't Laar A., Thien T.: Deleterious effects of anabolic steroids on serum lipoproteins, blood pressure, and liver function in amateur bodybuilders. Int J Sports Med 9. 19-23.1988; Abstrac 36 Lajarin F., Zaragoza R., r I., ez- P.: Evolution of serum lipids in two male bodybuilders using anabolic steroids. Clin Chem 42. 970- 972.1996; Abstract 37 McKillop G., Ballantyne D.: Lipoprotein analysis in bodybuilders. Int J Cardiol 17. 281-288.1987; Abstract 38 Palatini P., Giada F., Garavelli G., Sinisi F., L., Michieletto M., Baldo-Enzi G.: Cardiovascular effects of anabolic steroids in weight-trained subjects. J Clin Pharmacol 36. 1132-1140.1996; Abstract 39 Baldo-Enzi G., Giada F., Zuliani G., Baroni L., Vitale E., Enzi G., Magnanini P., Fellin R.: Lipid and apoprotein modifications in body builders during and after self- administration of anabolic steroids. Metabolism 39. 203-208.1990; Abstract 40 Fröhlich J., Kullmer T., Urhausen A., Bergmann R., Kindermann W.: Lipid profile of body builders with and without self-administration of anabolic steroids. Eur J Appl Physiol 59. 98-103.1989; 41 Hartgens F., Rietjens G., K 41 Hartgens F., Rietjens G., Keizer H.A., Kuipers H., Wolffenbuttel B.: Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a). Br J Sport Med 38. 253-259.2004; 42 Lane H., Grace F., J.C., K., Cockcroft J., Scanlon M.F., Davies J.S.: Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids. Eur J Clin Invest 36. 483-488.2006; Abstract 43 Urhausen A., Albers T., Kindermann W.: Are the cardiac effects of anabolic steroid abuse in strength athletes reversible?. Heart 90. 496-501.2004; Abstract 44 Zuliani U., Bernardini B., Catapano A., Campana M., Cerioli G., Spattini M.: Effects of anabolic steroids, testosterone, and HGH on blood lipids and echocardiographic parameteres in body builders. Int J Sports Med 10. 62-66.1989; Abstract 45 Glazer G.: Atherogenic effects of anabolic steroids on serum lipid levels. A literature reviewArch Intern Med 151. 1925-1933.1991; Abstract AAS, acute MI, and sudden death Alarming data have linked AAS with fatal events, although these are mostly case-control studies and case reports of acute coronary syndromes, MIs, and ventricular arrhythmias. [24] , [46] , [83] , [84] , [85] , [86] , [87] , [88] 88 Fineschi V., Riezzo I., Centini F., Silingardi E., Licata M., Beduschi G., Karch S.B.: Sudden cardiac death during anabolic steroid abuse: morphologic and toxicologic findings in two fatal cases of bodybuilders. Int J Legal Med 121. 48-53.2007; Abstract 89 Sullivan M.L., ez C.M., Gennis P., Gallagher E.J.: The cardiac toxicity of anabolic steroids. Prog Cardiovasc Dis 41. 1-15.1998; Abstract 90 Ferenchick G.: Anabolic/androgenic steroid abuse and thrombosis: is there a connection?. Med Hypotheses 35. 27-31.1991; Abstract 91 Roeggia M., Heinz G., Werba E., Roeggla G.: Cardiac tamponade in a 21-year-old body builder with anabolica abuse. Br J Clin Pract 50. 411-412.1996; Citation 92 Ferenchick G., Adelman S.: Myocardial infarction associated with anabolic steroid use in a previously healthy 37-year-old weight lifter. Am Heart J 124. 507- 508.1992; Citation 93 Huie M.: An acute myocardial infarction occurring in an anabolic steroid user. Med Sci Sport Exer 26. 408-413.1994; 94 Fisher M., Appleby M., Rittoo D., Cotter L.: Myocardial infarction with extensive intracoronary thrombus induced by anabolic steroids. Br J Clin Pract 50. 222- 223.1996; Abstract a postmortem study of male Caucasian AAS abusers (aged 20 to 45 years) suggested primary cardiac pathology in 1/3, [23] 23 Thiblin I., Lindquist O., Rajs J.: Cause and manner of death among users of anabolic androgenic steroids. J Forensic Sci 45. 16-23.2000; Abstract recent case-control study [24] , [25] suggested cardiac causes in 2/3 of deaths, with others being attributed to suicide, hepatic coma, and malignancy. 24 Parssinen M., Kujala U., Vartiainen E., Sarna S., Seppala T.: Increased premature mortality of competitive powerlifters suspected to have used anabolic agents. Int J Sports Med 21. 225-227.2000; Abstrac 25 Parssinen M., Seppala T.: Steroid use and long-term health risks in former athletes. Sports Med 2002. 83-84.2002; 2 Hausmann et al [84] describe a 23-year-old male bodybuilder who abused AAS and experienced sudden cardiac arrest. Postmortem examination revealed ventricular hypertrophy, myocardial fibrosis, and acute MI, and the cause of death was attributed to arrhythmic sudden death secondary to AAS abuse. 84 Hausmann R., Hammer S., Betz P.: Performance enhancing drugs (doping agents) and sudden death—a case report and review of the literature. Int J Legal Med 111. 261-264.1998; Abstrac McNutt et al[46] reported an acute MI in a 22-year-old bodybuilder who admitted to AAS abuse but lacked cardiac risk factors. The patient presented with markedly elevated LDL (596 mg/dl) and depressed HDL (14 mg/dl) yet had no family history of premature atherosclerosis or cardiac events. Within a month of discontinuing AAS, his LDL decreased to 220 mg/dl and his HDL increased to 35 mg/dl. 46 McNutt R.A., Ferenchick G.S., Kirlin P.C., Hamlin N.J.: Acute myocardial infarction in a 22-year-old world class weight lifter using anabolic steroids. Am J Cardiol62.164.1988; Citation 49 Bowman S.: Anabolic steroids and infarction. BMJ 300. 750.1990; Citation Figure 1 shows the presenting electrocardiogram of a 25-year-old male athlete who abused nandrolone and presented with an acute MI without traditional cardiac risk factors. Acute angiography revealed extensive left anterior descending coronary artery thrombosis, which was managed by thrombolysis. Angiography in the subacute phase confirmed very mild luminal irregularity at the site of previous thrombosis. 69 Kennedy C.: Myocardial infarction in association with misuse of anabolic steroids. Ulster Med J 62. 174-176.1993; Citation The most commonly observed arrhythmias, typically occurring during physical exertion, include atrial fibrillation, ventricular fibrillation, ventricular tachycardia, and supraventricular and ventricular ectopic beats. [95] 95 Furlanello F., Serdoz L.V., Cappato R., De Ambroggi L.: Illicit drugs and cardiac arrhythmias in athletes. Eur J Cardiovasc Prev Rehabil 14. 487-494.2007; Abstract Dickerman et al [96] reported a 20-year-old male bodybuilder who self-administered AAS 700 mg/week and had sudden cardiac arrest. Autopsy indicated LVH with a cardiac mass >2 times the upper limit of normal. 96 Dickerman R.D., Schaller F., Prather I., McConathy W.J.: Sudden cardiac death in a 20-year-old bodybuilder using anabolic steroids. Cardiology 86. 172-173.1995; Abstract ****************** Ralph Giarnella MD Southington Ct. USA? Quote
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.